Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.534
+0.034 (2.26%)
Mar 31, 2025, 2:11 PM EDT - Market open

Boundless Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-65.36-49.43-45.9-25.21
Depreciation & Amortization
1.090.960.940.68
Loss (Gain) From Sale of Investments
-5.06-3.30.50.54
Stock-Based Compensation
7.523.342.291.16
Other Operating Activities
2.652.391.70.42
Change in Accounts Payable
0.781.661.911.22
Change in Other Net Operating Assets
-2.45-2.46-1.05-2.06
Operating Cash Flow
-60.84-46.86-39.6-23.25
Capital Expenditures
-2.54-0.63-1.07-2.03
Investment in Securities
-23.57-37.6317.2-57.25
Investing Cash Flow
-26.1-38.2616.13-59.29
Issuance of Common Stock
93.170.180.130.21
Other Financing Activities
-3.35-1.96--
Financing Cash Flow
89.8297.90.13105.53
Net Cash Flow
2.8812.78-23.3422.99
Free Cash Flow
-63.38-47.49-40.66-25.28
Free Cash Flow Per Share
-3.73-39.05-37.04-29.38
Levered Free Cash Flow
-37.58-30.95-24.76-
Unlevered Free Cash Flow
-37.58-30.95-24.76-
Change in Net Working Capital
-2.150.36-2.12-
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q